Hi All, I'm a new member to this list, but there is a lot of material about the harms and concerns behind Closed Generics. In preparation for the meeting later today, I'll post some of it. I'm copying Michele Neylon, who was a leader in sharing concerns about Closed Generics with the ICANN Community in 2013. I don't think there is the time to prepare a robust debate for today, but hopefully at your next meeting, you might invite some of the names (people & their organizations) that you see in these materials into the discussion. There are also Community Objections on this issue that you might want to evaluate. Best regards, Kathy (Kleiman) ----------------------------------------------------------------- https://forum.icann.org/lists/comments-closed-generic-05feb13/msg00174.html Dear Sir / Madam I am submitting these comments on behalf of Blacknight, Ireland's only ICANN accredited registrar. They do not reflect the formal views of any stakeholder group, but those of our company. We are on the record with respect to our views on this issue, having spoken during the public forum at ICANN Toronto (http://toronto45.icann.org/node/34215) and having sent several letters to ICANN's board, which were co-signed by a broad cross-section of the ICANN Community: http://newgtlds.icann.org/en/program-status/correspondence/neylon-et-al-to-c... http://newgtlds.icann.org/en/program-status/correspondence/neylon-et-al-to-c... Rather than rehash our previous arguments I would prefer to simply state that they are unchanged. I've summarised some of the issues we see with them here: http://www.internetnews.me/2013/02/23/5-reasons-why-closed-generic-new-gtlds... It is also worth noting that our views are shared by some very large brands who have taken the time to submit very rational comments on this topic. But more importantly both consumer and trade organisations representing large numbers of internet users and businesses have too. Regards Michele Mr Michele Neylon Blacknight Solutions ♞ Hosting & Domains ICANN Accredited Registrar http://www.blacknight.co http://blog.blacknight.com/ Intl. +353 (0) 59 9183072 US: 213-233-1612 Locall: 1850 929 929 Facebook:http://fb.me/blacknight Twitter:http://twitter.com/mneylon ------------------------------- Blacknight Internet Solutions Ltd, Unit 12A,Barrowside Business Park,Sleaty Road,Graiguecullen,Carlow,Ireland Company No.: 370845 On 4/12/2017 4:45 AM, Michael Flemming wrote:
Dear All,
Please find the material that we will be referring to in order to address potential harms of Closed Generics.
Kind regards,
Michael Flemming
On Mon, Apr 10, 2017 at 6:28 PM, Michael Flemming <flemming@brightsconsulting.com <mailto:flemming@brightsconsulting.com>> wrote:
Dear All,
This week on 13 April 2017 at 21 UTC we will be once again discussing Closed Generics. As of our last meeting, we went through the Pros and Cons of Closed Generics by looking at the comments made in the Public Comments. We have not reached a consensus on anything at this point, however, we have not had a lot of input for the Cons and potential harm of Closed Generics at the current time. This week we will try to distinguish what potential harm exists if Closed Generics were allowed by analyzing the Public Comments even further. I welcome anyone who would like to assist in this discussion and analysis by joining us this week. Below is the agenda.
1. /Welcome
/ 2. /SOI
/ 3. /Closed Generics/
4. /AOB/
I look forward to speaking with everyone and having an exciting conversation!
Kind regards,
Michael Flemming
_______________________________________________ Gnso-newgtld-wg-wt2 mailing list Gnso-newgtld-wg-wt2@icann.org https://mm.icann.org/mailman/listinfo/gnso-newgtld-wg-wt2